1. Introduction {#sec1}
===============

Mesenchymal stem cells (MSCs) are a type of adult stem cells with the capacity to generate a wide range of cells such as adipocytes, osteoblasts, chondrocytes, and myocytes \[[@B1]\]. Being originally identified from the bone marrow, MSCs now can be isolated from many other tissues including adipose tissue, placenta, and umbilical cord. MSCs also possess potent immunoregulatory abilities through interactions with both the adaptive and the innate immune cells. The immunomodulatory effect of MSCs is mediated by the secretion of soluble factors and/or by cell-cell contact-dependent regulation. These features make MSCs an interesting cell resource for tissue regeneration and cellular therapy.

Recently, the findings of functional toll-like receptors (TLRs) expression on MSC implicate these receptors in modulating MSCs functions \[[@B2]\]. TLRs are pattern recognition receptors involved in the recognition of pathogen-associated molecular patterns (PAMP) by immune cells, initiating both primary and adaptive immune responses \[[@B3]\]. To date, thirteen mammalian TLR analogs have been identified (10 in humans and 13 in mice). Beside their important roles in immunity, TLRs have also been recognized as regulators of stem cells functions, including cell growth, differentiation, and survival. For instance, De Luca et al. showed that TLR1/2 signaling instructed commitment of human hematopoietic stem cells to a myeloid cell fate \[[@B4]\]. Qi et al. demonstrated that both TLR3 and TLR4 promoted differentiation of bone marrow MSCs to osteoblasts \[[@B5]\].

In the field of immunology, recent publications have shown widespread changes in the expression of lncRNAs during the activation of the innate immune response and T cell development, differentiation, and activation \[[@B6]\]. It is well known that TLRs and their specific stimulus activate MyD88-dependent or -independent downstream signaling pathways. However, whether epigenetic regulators such as long noncoding RNA are involved in this process remains unclear. In this study, we determined the TLR expression profile of adipose tissue derived MSCs (AD-MSCs) and the consequences of TLR3 ligation in terms of cytokine secretion by these cells. To explore the potential involvement of lncRNAs in TLR stimulated MSCs, we performed comprehensive lncRNA and mRNA profiling through microarray. 10.2% of lncRNAs (1733 out of 16967) and 15.1% of mRNA transcripts (1760 out of 11632) were significantly differentially expressed (absolute fold-change ≥5, *P* value ≤ 0.05) in TLR3 stimulated MSCs. Furthermore, we characterized the differentially expressed lncRNAs through their classes and length distribution and correlated them with differentially expressed mRNA. To the best of our knowledge, this is the first study that links TLR3 with lncRNAs in MSCs.

2. Materials and Methods {#sec2}
========================

2.1. Isolation and Culture of AD-MSCs {#sec2.1}
-------------------------------------

Adipose tissues were obtained from patients undergoing tumescent liposuction according to procedures approved by the Ethics Committee at the Chinese Academy of Medical Sciences and Peking Union Medical College. AD-MSCs were isolated and culture-expanded as previously reported \[[@B1], [@B7]\]. Passage 3 cells were used for the experiments.

2.2. Adipogenic and Osteogenic Differentiation of AD-MSCs {#sec2.2}
---------------------------------------------------------

Adipogenic differentiation was induced in high glucose of Dulbecco\'s Modified Eagle\'s Medium (H-DMEM) supplemented with 10% FBS, 1 *μ*M dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 5 *μ*g/mL 0.1 mM l-ascorbic acid. After being cultured in adipocyte induction medium for 4 days, medium was replaced with adipocyte maintaining medium, H-DMEM, with 10% FBS. For osteogenic differentiation, AD-MSCs were cultured in H-DMEM containing 10% FBS, 10 mM *β*-glycerophosphate, 50 *μ*mM l-ascorbic acid, and 0.01 *μ*M dexamethasone for 14 days.

2.3. ALP and Oil Red O Staining {#sec2.3}
-------------------------------

The procedure of ALP staining was performed according to the manufacturer\'s instructions of ALP staining kit (Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences). For oil red O staining, cells were washed twice with PBS and fixed with 10% formalin for 10 min at room temperature. After fixation, cells were stained with filtered oil red O solution (stock solution: 3 mg/mL in isopropanol, working solution: 60% oil red O stock solution and 40% distilled water) for 1 h at room temperature. After staining, cells were washed with water to remove unbound dye, visualized by light microscopy, and photographed.

2.4. Real-Time Polymerase Chain Reaction Analysis {#sec2.4}
-------------------------------------------------

Total RNA was extracted with TRIzol (Invitrogen), and cDNA was prepared. Real-time polymerase chain reaction (PCR) was amplified in triplicates according to manufacturer\'s procedures (TaKaRa). Relative expression of mRNA was evaluated by 2^−ΔΔCt^ method and normalized to the expression of GAPDH.

2.5. Cytokines Production {#sec2.5}
-------------------------

AD-MSCs were seeded in 12-well plate in culture medium with or without Poly I:C. Supernatants were collected after 24 h and concentrations of IL-1*β*, IL-4, IL-6, IL-8, IL-10, IL-12, TNF-*α*, TGF*β*, and IFN-*γ* were determined by enzyme-linked immunosorbent assay (ELISA) (R&D system) according to the manufacturer\'s instructions.

2.6. Microarray and Data Analysis {#sec2.6}
---------------------------------

Arraystar Human LncRNA Microarray V3.0 is designed for the global profiling of human LncRNAs and protein-coding transcripts, which is updated from the previous microarray V2.0. About 30,586 LncRNAs and 26,109 coding transcripts can be detected by our third-generation LncRNA microarray. The LncRNAs are carefully constructed using the most highly respected public transcriptome databases (Refseq, UCSC knowngenes, Gencode, etc.), as well as landmark publications. Each transcript is represented by a specific exon or splice junction probe which can identify individual transcript accurately. Total RNA was extracted and examined for quality control before array. The OD260/OD280 ratios were approximately 2.0, and the OD260/OD230 ratios were more than 1.8 (Supplementary Table 1 in Supplementary Material available online at <http://dx.doi.org/10.1155/2016/6205485>). Positive probes for housekeeping genes and negative probes are also printed onto the array for hybridization quality control. (1) RNA labeling and array hybridization are as follows: sample labeling and array hybridization were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology) with minor modifications. Briefly, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY Eukaryotic mRNA Isolation Kit, Epicentre). Then, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3′ bias utilizing a random priming method (Arraystar Flash RNA Labeling Kit, Arraystar). The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen). The concentration and specific activity of the labeled cRNAs (pmol Cy3/*μ*g cRNA) were measured by NanoDrop ND-1000. 1 *μ*g of each labeled cRNA was fragmented by adding 5 *μ*L 10× blocking agent and 1 *μ*L of 25× fragmentation buffer and then the mixture was heated at 60°C for 30 min; finally, 25 *μ*L 2× GE hybridization buffer was added to dilute the labeled cRNA. 50 *μ*L of hybridization solution was dispensed into the gasket slide and assembled to the LncRNA expression microarray slide. The slides were incubated for 17 hours at 65°C in an Agilent Hybridization Oven. The hybridized arrays were washed, fixed, and scanned using the Agilent DNA Microarray Scanner (part number G2505C). Quality control for labeling efficiency was shown in Supplementary Table 2.

\(2\) Data analysis is as follows: slides were scanned at 5 lm/pixel resolution using an Axon GenePix 4000B scanner (Molecular Devices Corporation) piloted by GenePix Pro 6.0 software (Axon). Scanned images (TIFF format) were then imported into NimbleScan software (version 2.5) for grid alignment and expression data analysis. Expression data were normalized through quantile normalization and the Robust Multichip Average (RMA) algorithm included in the NimbleScan software. The probe level files and mRNA level files were generated after normalization. All gene level files were imported into Agilent GeneSpring GX software (version 11.5.1) and normalized by the quantile method; then, Combat software was used to adjust the normalized intensity to remove batch effects. Hierarchical clustering was performed using Agilent GeneSpring GX software (version 11.5.1). The analysis was performed by KangChen Biotech., Shanghai, China. Agilent Feature Extraction software (version 11.0.1.1) was used to analyze acquired array images. We have four samples; three were control MSCs and one is TLR3-activated MSCs. LncRNAs and mRNAs that have flags in Present or Marginal (all targets value) in at least 2 out of the 3 control MSCs samples were chosen for further data analysis. Differentially expressed LncRNAs and mRNAs with statistical significance between the two groups were identified through *P* value/FDR filtering. Hierarchical clustering and combined analysis were performed using homemade scripts. For gene ontology analysis, Fisher\'s exact test was used to determine whether the overlap between the differentially expressed gene list and the GO annotation list was greater than that expected by chance. The *P* value denotes the significance of GO term enrichment in the differentially expressed genes.

3. Results {#sec3}
==========

3.1. Characterization of AD-MSCs and the Expression Pattern of TLRs {#sec3.1}
-------------------------------------------------------------------

We isolated and expanded plastic adherent, spindle-like mesenchymal stem cells from adipose tissue ([Figure 1(a)](#fig1){ref-type="fig"}). AD-MSCs expressed high levels of CD29, CD44, and CD105 but were persistently negative for CD31, CD34, and HLA-DR ([Figure 1(b)](#fig1){ref-type="fig"}). Osteogenic differentiation was detected by Alizarin red staining and ALP activity assay ([Figure 1(c)](#fig1){ref-type="fig"}). Adipogenic differentiation was demonstrated by oil red O staining ([Figure 1(c)](#fig1){ref-type="fig"}). The expression of TLRs in MSCs remains controversial. PCR primers specific to TLR-1 and to TLR-10 were designed to detect TLRs from total RNA in AD-MSCs ([Table 1](#tab1){ref-type="table"}). RT-PCR results showed that all TLRs were detectable within 33 cycles and that TLR3 has the highest expression level ([Figure 1(d)](#fig1){ref-type="fig"}).

3.2. Effect of TLR3 Agonist on Cytokine Expression of AD-MSCs {#sec3.2}
-------------------------------------------------------------

Since TLR3 had the highest expression level, to evaluate its functionality, we stimulated AD-MSCs with TLR3 agonist (Poly I:C 20 *μ*g/mL) for 24 h and determined its effect on cell proliferation and cytokine secretion. Poly I:C slightly decreased proliferation of AD-MSCs ([Figure 2(a)](#fig2){ref-type="fig"}). Flow cytometry analysis of cell cycles showed that Poly I:C stimulated AD-MSCs had enhanced G2 phase ([Figure 2(b)](#fig2){ref-type="fig"}). We measured a number of cytokines known to be involved in immunomodulation, including IL-1*β*, IL-4,IL-6, IL-8, IL-10, IL-12, TNF-*α*, TGF*β*, and IFN-*γ*. We found that Poly I:C induced upregulation of IL-1*β*, IL-6, IL-8, and TNF-*α* as measured by RT-PCR ([Figure 2(c)](#fig2){ref-type="fig"}). Enhanced release of these cytokines was also detected by ELISA ([Figure 2(d)](#fig2){ref-type="fig"}). Exposure to poly (I:C) also increased the expression of TLR3 ([Figure 2(e)](#fig2){ref-type="fig"}).

3.3. Overview of lncRNA and mRNA Profiles in TLR3-Activated AD-MSCs and Control AD-MSCs {#sec3.3}
---------------------------------------------------------------------------------------

To examine the lncRNA expression profiles in AD-MSCs treated with or without TLR3 agonist, we used Arraystar Human LncRNA Microarray V3.0 which contains 30,586 lncRNA probes, collected from RefSeq, UCSC knowngenes, Gencode, and so forth, and 26,109 mRNA probes. The overview of lncRNA expression profiles is summarized in [Table 2](#tab2){ref-type="table"} and [Figure 3(a)](#fig3){ref-type="fig"}. Overall, we found that 55.5% of lncRNAs (16967 out of 30586) and 44.5% of protein-coding mRNA transcripts (11632 out of 26109) on the microarray exhibited expression above background. 10.2% of lncRNAs (1733 out of 16967) and 15.1% of protein-coding mRNA transcripts (1760 out of 11632) were significantly differentially expressed (absolute fold-change ≥5, *P* value ≤ 0.05) between TLR3-activated AD-MSCs and control AD-MSCs. The top 10 up- and downregulated LncRNAs in TLR3-activated AD-MSCs compared to control AD-MSCs were shown in [Table 3](#tab3){ref-type="table"}. [Figure 3(b)](#fig3){ref-type="fig"} showed the hierarchical cluster of lncRNAs expression in Poly I:C stimulated AD-MSCs and nonstimulated AD-MSCs. Additionally, statistical analysis showed that the expressed lncRNAs were widely distributed on all chromosomes ([Figure 3(c)](#fig3){ref-type="fig"}) and that chr1 had the most expressed lncRNAs, while the mitochondrial genome had the least.

3.4. Characteristics of LncRNAs with Changed Expression in TLR3-Activated AD-MSCs {#sec3.4}
---------------------------------------------------------------------------------

Among the 7271 differentially expressed LncRNA (absolute fold-change ≥2, *P* value ≤ 0.05), 2155 lncRNAs were upregulated in experimental group compared to the control group, while 5116 lncRNAs were downregulated. Here, one upregulated lncRNA uc010kun.2 was of particular interest for us because it is located upstream of IL6, a cytokine induced after TLR3 activation in AD-MSCs. Using qPCR, we observed a 2.70-fold upregulation in uc010kun.2, consistent with microarray analysis results (2.63-fold-change) (Supplementary Figure 1). [Table 3](#tab3){ref-type="table"} showed the top 10 up- and downregulated lncRNAs in TLR3-activated AD-MSCs versus control AD-MSCs. We classified these differentially expressed LncRNAs into 6 groups: "sense-overlapping," the LncRNA\'s exon is overlapping a coding transcript exon on the same genomic strand; "intronic," the LncRNA is overlapping the intron of a coding transcript on the same genomic strand; "natural antisense," the LncRNA is transcribed from the antisense strand and overlapping with a coding transcript; "nonoverlapping antisense," the LncRNA is transcribed from the antisense strand without sharing overlapping exons; "bidirectional," the LncRNA is oriented head to head to a coding transcript within 1000 bp; "intergenic": there are no overlapping or bidirectional coding transcripts nearby the LncRNA. [Figure 4(a)](#fig4){ref-type="fig"} showed the distribution of the six classes of LncRNAs with changed expression in TLR3-activated AD-MSCs. The lncRNAs are mainly between 200 bp and 3000 bp in length. [Figure 4(b)](#fig4){ref-type="fig"} showed the length distribution of differentially expressed lncRNAs. The majority of the differentially expressed lncRNAs have a length between 500 bp and 1000 bp.

3.5. Gene Ontology and Pathway Analysis {#sec3.5}
---------------------------------------

GO analysis was performed to determine the gene and gene product enrichment in biological processes, cellular components, and molecular functions (Supplementary Figure 2). We found that the highest enriched GOs targeted by upregulated mRNAs in TLR3-activated MSCs were mRNA metabolic process (ontology: biological process) ([Figure 5(a)](#fig5){ref-type="fig"}), intracellular part (ontology: cellular component) ([Figure 5(b)](#fig5){ref-type="fig"}), and structural constituent of ribosome (ontology: molecular function) ([Figure 5(c)](#fig5){ref-type="fig"}). The highest enriched GOs targeted by the downregulated transcripts in TLR3-activated MSCs were response to external stimulus (ontology: biological process) ([Figure 5(d)](#fig5){ref-type="fig"}), ankyrin binding (ontology: cellular component) ([Figure 5(e)](#fig5){ref-type="fig"}), and intrinsic to plasma membrane (ontology: molecular function) ([Figure 5(f)](#fig5){ref-type="fig"}). Specifically, we analyzed expression of genes associated with immune response (GO:0006955 [Figure 6(a)](#fig6){ref-type="fig"}), genes associated with immune response-regulation signaling pathway (GO:0002764 [Figure 6(b)](#fig6){ref-type="fig"}), and genes associated with regulation of immune response (GO:0050776 [Figure 6(c)](#fig6){ref-type="fig"}). Additionally, other genes associated with immune response (GO:0050778, GO:0042092, GO:0002828, GO:0002920, and GO:0002821) were analyzed (Supplementary Figure 3). Pathway analysis indicated that 38 pathways were upregulated and 31 were downregulated in TLR3-activated MSCs. [Figure 7](#fig7){ref-type="fig"} showed the top 10 of the changed pathways.

4. Discussion {#sec4}
=============

TLRs play an important role in innate and adaptive immunity. The expression and function of multiple TLRs have been described in many cell types, especially in cells of the innate immune system, where they function as sensors of infection or damage \[[@B8], [@B9]\]. However, conflicting results have been reported because TLRs expressed on different cell types from different species and tissues resulted in different responses \[[@B10]\]. Recently, it has been reported that MSC derived from adult bone marrow also expresses functional TLRs that promote their survival and proinflammatory cytokine secretion \[[@B11]\]. Here, we show that AD-MSCs express 10 types of TLRs and the expression level of TLR3 was the highest. Activation of TLR3 in AD-MSCs leads to enhanced secretion of IL-1*β*, IL-6, IL-8, and TNF-*α*.

It is well known that TLRs and their specific stimulus activate MyD88-dependent or -independent downstream signaling pathways. However, whether epigenetic regulators such as long noncoding RNA are involved in this process remains unclear. lncRNAs are over 200 nucleotides in length and are separate from the other known ncRNA subsets. Previous studies have focused primarily on short noncoding RNAs, such as microRNAs, transfer RNAs, and short interfering RNAs. Increasing evidence confirmed lncRNAs to be one of the most important factors controlling gene expression and the aberrant expression of which is involved in a variety of human diseases, including immunological disorders \[[@B12], [@B13]\]. Guttman et al. were the first to use the intergenic deposition of epigenetic marks to identify 20 lncRNAs induced in lipopolysaccharide- (LPS-) stimulated mouse bone marrow-derived dendritic cells (BMDD) \[[@B14]\]. Later on, several lncRNAs have been identified following activation of monocytes, macrophages, fibroblasts, and dendritic cells \[[@B15]--[@B18]\]. The potential importance of lncRNAs in the immune response is only now emerging. Immune-related lncRNAs are generally identified through examination of differential expression in response to activation of immune cells \[[@B6]\]. Here, a major focus of our study was to define the repertoire of lncRNAs in TLR3-activated AD-MSCs. We performed comprehensive lncRNA and mRNA profiling through microarray and found 10.2% of lncRNAs (1733 out of 16967) and 15.1% of mRNA transcripts (1760 out of 11632) were significantly differentially expressed in TLR3 stimulated MSCs. Furthermore, we characterized the differentially expressed lncRNAs through their classes and length distribution and correlated them with differentially expressed mRNA.

An interesting observation from sequencing data is that many of the immune-related lncRNAs are located close to, or partially overlapping, the 5′ end (upstream) or 3′ end (downstream) of protein-coding genes implicated in the immune response \[[@B6], [@B19]\]. Here, one upregulated lncRNA uc010kun.2 was of particular interest for us because it is located upstream of IL6, a cytokine induced after TLR3 activation in AD-MSCs. Another lncRNA our data may highlight is lncRNA-Cox7A2. Carpenter et al. indicated that Cox2 and lncRNA-Cox2 regulated by MyD88 and NF-kB were markedly induced after TLR4 stimulation in BMDMs \[[@B17]\]. Here, lncRNA-Cox7A2 is predicted to be associated with Cox7A2, which is also a cytochrome c oxidase subunit.

TLR3 signaling and subsequent inflammatory responses are controlled by a multitude of regulatory molecules. Here, we propose a model whereby TLR3 signaling induces expression changes of lncRNAs which then exert their effects as repressors or activators of genes through interactions with various regulatory complexes. As such, lncRNAs represent a new component of the TLR3 signaling pathway.

In summary, our study was the first to demonstrate that a set of lncRNAs is significantly regulated in AD-MSCs upon stimulation with TLR3, suggesting a role of lncRNAs in the immune response of AD-MSCs. This will provide the basis for the subsequent functional and mechanistic analysis of individual lncRNAs. Currently, the precise functions of the differentially expressed lncRNAs remain largely unknown and advances in the understanding of their role will allow us to tackle a range of challenges in AD-MSCs immunomodulatory properties.

Highlights {#sec5}
==========

TLR3 is highly expressed in adipose tissue derived mesenchymal stem cells.TLR3 agonist Poly I:C promotes secretion of a variety of cytokines.TLR3-activated AD-MSCs show dynamic changes in lncRNA and mRNA profiles.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Supplementary Table 1 demonstrated the RNA quantification and quality assurance of four samples (one is TLR3-activated MSCs, three are control MSCs); table 2 showed the quality control for labeling efficiency during the microarray. Supplementary figure 1 showed the consistence between microarray and qPCR results using uc010kun.2 as an example; figure 2 was GO analysis of differentially expressed genes according to biological process, cellular component and molecular function classification; figure 3 was GO analysis of a set of specific genes associated with immune response.
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![Characterization of AD-MSCs and the expression pattern of TLRs. (a) The cell morphology of AD-MSCs observed under light microscope. (b) Immunophenotype of AD-MSCs. (c) Differentiation capacity of AD-MSCs was demonstrated by ALP staining (left) and Alizarin red staining (centered) for osteoblasts and oil red O staining for adipocytes (right). (d) The expression levels of TLRs were analyzed by real-time PCR.](SCI2016-6205485.001){#fig1}

![Effect of TLR3 agonist on AD-MSCs. (a) Effect of TLR3 agonist on the proliferation of AD-MSCs. (b) Cell cycle analysis of Poly I:C stimulated AD-MSCs and control AD-MSCs. (c) Cytokine secretion of AD-MSCs after Poly I:C stimulation as detected by RT-PCR. (d) Cytokine secretion of AD-MSCs after Poly I:C stimulation as detected by ELASA. (e) TLR3 expression in Poly I:C stimulated AD-MSCs and control AD-MSCs.](SCI2016-6205485.002){#fig2}

![Overview of lncRNA profiles in TLR3-activated AD-MSCs and control AD-MSCs. (a) The scatter plot is a visualization method used for assessing the lncRNA expression variations between TLR3-activated AD-MSCs and control AD-MSCs. The values of the *X* and *Y* axes in the scatter plot are the averaged normalized signal values of the group (log 2 scale). The green lines are fold-change lines (the default fold-change given is 2). (b) Hierarchical clustering of lncRNAs in TLR3-activated AD-MSCs and control AD-MSCs. (c) Chromosomal distribution of detected lncRNAs.](SCI2016-6205485.003){#fig3}

![Characteristics of LncRNAs with changed expression in TLR3-activated AD-MSCs. (a) Distribution of various classes of differentially expressed LncRNAs. The ratio of 6 classes (sense overlap LncRNAs, antisense overlap LncRNAs, bidirectional LncRNAs, and intergenic LncRNAs) in total changed LncRNAs was analyzed in TLR3-activated AD-MSCs. (b) Length distribution of differentially expressed lncRNAs in TLR3-activated AD-MSCs.](SCI2016-6205485.004){#fig4}

![GO term enrichment in the differentially expressed genes. (a, b, c) Genes upregulated in TLR3-activated AD-MSCs. (d, e, f) Genes downregulated in TLR3-activated AD-MSCs.](SCI2016-6205485.005){#fig5}

![Gene ontology analysis of genes (a) associated with immune response GO:0006955, (b) genes associated with immune response-regulation signaling pathway GO:0002764, and (c) genes associated with regulation of immune response GO:0050776.](SCI2016-6205485.006){#fig6}

![Pathway analysis of the differentially expressed genes. (a) Top 10 of the upregulated pathways in TLR3-activated AD-MSCs. (b) Top 10 of the downregulated pathways in TLR3-activated AD-MSCs.](SCI2016-6205485.007){#fig7}

###### 

PCR primers specific to TLR-1 and to TLR-10.

  Gene    Sense primer (5′\~3′)     Antisense primer (5′\~3′)
  ------- ------------------------- ---------------------------
  TLR1    CCACGTTCCTAAAGACCTATCCC   CCAAGTGCTTGAGGTTCACAG
  TLR2    ATCCTCCAATCAGGCTTCTCT     GGACAGGTCAAGGCTTTTTACA
  TLR3    TTGCCTTGTATCTACTTTTGGGG   TCAACACTGTTATGTTTGTGGGT
  TLR4    AGACCTGTCCCTGAACCCTAT     CGATGGACTTCTAAACCAGCCA
  TLR5    TCCCTGAACTCACGAGTCTTT     GGTTGTCAAGTCCGTAAAATGC
  TLR6    TGAATGCAAAAACCCTTCACCT    CCAAGTCGTTTCTATGTGGTTGA
  TLR7    CACATACCAGACATCTCCCCA     CCCAGTGGAATAGGTACACAGTT
  TLR8    ATGTTCCTTCAGTCGTCAATGC    TTGCTGCACTCTGCAATAACT
  TLR9    CTGCCACATGACCATCGAG       GGACAGGGATATGAGGGATTTGG
  TLR10   GGTTCTTTTGCGTGATGGAATC    GGTCGTCCCAGAGTAAATCAAC

###### 

Summary of microarray analysis results.

  -----------------------------------------------------------------------------------
  Probe class   Total    Expressed above background   Differentially expressed^*∗*^
  ------------- -------- ---------------------------- -------------------------------
  LncRNA\       30586\   16967 (55.5%) \              1733 (10.2%)\
  mRNA\         26109\   11632 (44.5%)\               1760 (15.1%)\
  Combined      56695    28599 (50.4%)                3493 (12.2%)

  -----------------------------------------------------------------------------------

^*∗*^Significant differential expression was defined as probes with *P*≤ 0.05 and absolute fold-change ≥5.

###### 

The top 10 up- and downregulated lncRNAs in TLR3-activated AD-MSCs versus control AD-MSCs.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                Top 10 LncRNAs   Chromosomal\   RNA length   Start locus   Stop locus   Associated\         Relationship
                                                                                 localization                                           gene name           
  ------------------------------------------------------------- ---------------- -------------- ------------ ------------- ------------ ------------------- -------------------
  TLR3-activated AD-MSCs versus control AD-MSCs upregulated     NR_052024        Chr20          803          33866708      33872520     EIF6                Sense-overlapping

  NR_037793                                                     Chr14            1853           50065414     50081390      LRR1         Sense-overlapping   

  ENST00000577672                                               Chr1             409            1655950      1667412       SLC35E2      Intronic            

  ENST00000430598                                               Chr15            4279           20613648     20711433                   Intergenic          

  ENST00000514727                                               Chr4             442            140036086    140036528                  Intergenic          

  NR_024596                                                     Cchr11           1129           86014397     86056985      C11orf73     Sense-overlapping   

  NR_027653                                                     Chr10            4525           3818187      3827473       KLF6         Sense-overlapping   

  uc002xij.3                                                    Chr20            805            37049238     37063962                   Intergenic          

  ENST00000478666                                               Chr3             1068           75471569     75484197                   Intergenic          

  uc010hbj.3                                                    Chr22            1172           51222224     51238065      RABL2B       Bidirectional       

                                                                                                                                                            

  TLR3-activated AD-MSCs versus control AD-MSCs downregulated   TCONS_00020653   Chr12          978          130442131     130444607                        Intergenic

  ENST00000428453                                               Chr15            4383           20588367     20711414                   Intergenic          

  CB112975                                                      Chr13            379            30229248     30229615                   Intergenic          

  uc009whu.1                                                    Chr1             2772           142853227    142855999                  Intergenic          

  TCONS_00013                                                   Chr7             1092           22450335     22452159                   Intergenic          

  ENST00000557155                                               Chr14            381            85860291     85886396                   Intergenic          

  ENST00000421735                                               Chr3             338            50304072     50304803      SEMA3B       Bidirectional       

  TCONS_00014720                                                Chr8             206            59129760     59131635                   Intergenic          

  ENST00000505736                                               Chr4             1668           137717876    138133953                  Intergenic          

  ENST00000568150                                               Chr16            547            48657346     48778553                   Intergenic          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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